Literature DB >> 18566381

Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells, and MHC class II.

Thomas Fehr1, Fabienne Haspot, Joshua Mollov, Meredith Chittenden, Timothy Hogan, Megan Sykes.   

Abstract

Allogeneic bone marrow chimerism induces robust systemic tolerance to donor alloantigens. Achievement of chimerism requires avoidance of marrow rejection by pre-existing CD4 and CD8 T cells, either of which can reject fully MHC-mismatched marrow. Both barriers are overcome with a minimal regimen involving anti-CD154 and low dose (3 Gy) total body irradiation, allowing achievement of mixed chimerism and tolerance in mice. CD4 cells are required to prevent marrow rejection by CD8 cells via a novel pathway, wherein recipient CD4 cells interacting with recipient class II MHC tolerize directly alloreactive CD8 cells. We demonstrate a critical role for recipient MHC class II, B cells, and dendritic cells in a pathway culminating in deletional tolerance of peripheral alloreactive CD8 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566381      PMCID: PMC2734139          DOI: 10.4049/jimmunol.181.1.165

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

Review 1.  Direct and indirect recognition: the role of MHC antigens in graft rejection.

Authors:  D S Gould; H Auchincloss
Journal:  Immunol Today       Date:  1999-02

2.  Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.

Authors:  A D Wells; M C Walsh; J A Bluestone; L A Turka
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  B cells productively engage soluble antigen-pulsed dendritic cells: visualization of live-cell dynamics of B cell-dendritic cell interactions.

Authors:  Ning-Na Huang; Sang-Bae Han; Il-Young Hwang; John H Kehrl
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

4.  Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.

Authors:  Thomas Fehr; Yasuo Takeuchi; Josef Kurtz; Thomas Wekerle; Megan Sykes
Journal:  Eur J Immunol       Date:  2005-09       Impact factor: 5.532

Review 5.  A case for regulatory B cells.

Authors:  Atsushi Mizoguchi; Atul K Bhan
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

6.  Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.

Authors:  Y Fudaba; T R Spitzer; J Shaffer; T Kawai; T Fehr; F Delmonico; F Preffer; N Tolkoff-Rubin; B R Dey; S L Saidman; A Kraus; T Bonnefoix; S McAfee; K Power; K Kattleman; R B Colvin; D H Sachs; A B Cosimi; M Sykes
Journal:  Am J Transplant       Date:  2006-06-22       Impact factor: 8.086

7.  Antibody-induced transplantation tolerance that is dependent on thymus-derived regulatory T cells.

Authors:  Shaoping Deng; Daniel J Moore; Xiaolun Huang; Mohammad Mohiuddin; Major K Lee; Ergun Velidedeoglu; Moh-Moh Lian; Meredith Chiaccio; Samsher Sonawane; Anton Orlin; Jing Wang; Haiying Chen; Andrew Caton; Robert Zhong; James F Markmann
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

Review 8.  Tolerogenic dendritic cells: cytokine modulation comes of age.

Authors:  Sergio Rutella; Silvio Danese; Giuseppe Leone
Journal:  Blood       Date:  2006-05-09       Impact factor: 22.113

Review 9.  A novel pathway of antigen presentation by dendritic and endothelial cells: Implications for allorecognition and infectious diseases.

Authors:  Lesley Ann Smyth; Osquel Barroso Herrera; Dela Golshayan; Giovanna Lombardi; Robert I Lechler
Journal:  Transplantation       Date:  2006-07-15       Impact factor: 4.939

10.  TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo.

Authors:  Yaiza Diaz-de-Durana; George T Mantchev; Richard J Bram; Alessandra Franco
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

View more
  23 in total

1.  Layers of regulation in induction of mixed chimerism by anti-CD40L.

Authors:  Carrie L Lucas; Megan Sykes
Journal:  Chimerism       Date:  2011 Oct-Dec

Review 2.  Transplantation tolerance through mixed chimerism.

Authors:  Nina Pilat; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2010-08-31       Impact factor: 28.314

Review 3.  Immuno-intervention for the induction of transplantation tolerance through mixed chimerism.

Authors:  David H Sachs; Megan Sykes; Tatsuo Kawai; A Benedict Cosimi
Journal:  Semin Immunol       Date:  2011-08-11       Impact factor: 11.130

Review 4.  Induction of tolerance through mixed chimerism.

Authors:  David H Sachs; Tatsuo Kawai; Megan Sykes
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

5.  Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway.

Authors:  Fabienne Haspot; Thomas Fehr; Carrie Gibbons; Guiling Zhao; Timothy Hogan; Tasuku Honjo; Gordon J Freeman; Megan Sykes
Journal:  Blood       Date:  2008-06-24       Impact factor: 22.113

6.  LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L.

Authors:  Carrie L Lucas; Creg J Workman; Semir Beyaz; Samuel LoCascio; Guiling Zhao; Dario A A Vignali; Megan Sykes
Journal:  Blood       Date:  2011-03-21       Impact factor: 22.113

Review 7.  Hematopoietic stem cell infusion/transplantation for induction of allograft tolerance.

Authors:  Jose M M Granados; Gilles Benichou; Tatsuo Kawai
Journal:  Curr Opin Organ Transplant       Date:  2015-02       Impact factor: 2.640

8.  Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients.

Authors:  K A Newell; A Asare; I Sanz; C Wei; A Rosenberg; Z Gao; S Kanaparthi; S Asare; N Lim; M Stahly; M Howell; S Knechtle; A Kirk; W H Marks; T Kawai; T Spitzer; N Tolkoff-Rubin; M Sykes; D H Sachs; A B Cosimi; W J Burlingham; D Phippard; L A Turka
Journal:  Am J Transplant       Date:  2015-10-13       Impact factor: 8.086

9.  CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance.

Authors:  Josef Kurtz; Forum Raval; Casey Vallot; Jayden Der; Megan Sykes
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

10.  Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunity.

Authors:  Olivier Renaudet; Gargi Dasgupta; Ilham Bettahi; Alda Shi; Anthony B Nesburn; Pascal Dumy; Lbachir BenMohamed
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.